Menstruation and Menstrual Disorders | MyMerci
제안하기
0 / 2000

Menstruation and Menstrual Disorders

Unit 1 · Topic 1Menstruation and Menstrual Disorders
1.Overview & Pathophysiology

The menstrual cycle is controlled by the hypothalamic–pituitary–ovarian axis. Gonadotropin-releasing hormone (GnRH) from the hypothalamus stimulates the anterior pituitary to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The ovary and the endometrium change in parallel.

PhaseOvaryEndometriumDominant hormones
Menstrual (days 1–5)New follicles recruitedFunctional layer shedsEstrogen and progesterone low
Follicular (day 1 to ovulation)FSH gradually rises and matures follicles; dominant follicle secretes estrogenProliferative phase — estrogen thickens the liningRising estrogen
Ovulation (about 14 days before the next period)LH surge releases the oocyte—LH peak, estrogen peak
Luteal (ovulation to menses)Corpus luteum secretes progesteroneSecretory phase — glands and blood supply prepare for implantationProgesterone high
  • The luteal phase is relatively constant (about 14 days); differences in cycle length come from the follicular phase. In a 35-day cycle, ovulation occurs around day 21 — count back 14 days from the expected next period.
  • If no pregnancy occurs, the corpus luteum regresses, progesterone falls, and the lining sheds.
  • Normal adult cycle: about 24–38 days, bleeding up to 8 days.
  • Basal body temperature rises about 0.3–0.5 °C (0.5–1 °F) after ovulation because of progesterone.

Common disorders

DisorderDefinition / key mechanism
Primary amenorrheaNo menses by age 15 with secondary sex characteristics (or no breast development by 13)
Secondary amenorrheaNo menses for 3 months with previously regular cycles, or 6 months with irregular cycles. Pregnancy is the most common cause
Abnormal uterine bleeding (AUB)Bleeding abnormal in frequency, regularity, duration, or volume. Causes classified by PALM-COEIN: Polyp, Adenomyosis, Leiomyoma, Malignancy/hyperplasia (structural); Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, Not yet classified
Heavy menstrual bleedingExcessive blood loss that interferes with quality of life (older definition: > 80 mL per cycle or > 7 days)
Frequent menstrual bleedingCycles shorter than 24 days — evaluate for structural causes (polyp, submucosal fibroid, adenomyosis) and ovulatory dysfunction
Primary dysmenorrheaPainful menses without pelvic pathology; excess prostaglandins cause uterine contractions and ischemia; begins with ovulatory cycles in adolescence
Secondary dysmenorrheaPain from pelvic pathology — endometriosis, adenomyosis, fibroids, PID
Premenstrual syndrome (PMS)Physical and emotional symptoms in the luteal phase that resolve within a few days after menses starts
Premenstrual dysphoric disorder (PMDD)Severe mood symptoms (irritability, depression, anxiety) causing marked impairment; a depressive disorder in DSM-5-TR
Polycystic ovary syndrome (PCOS)Ovulatory dysfunction, hyperandrogenism, and polycystic ovaries; strongly linked to insulin resistance
HyperprolactinemiaProlactin suppresses GnRH → amenorrhea, galactorrhea; prolactinoma, hypothyroidism, antipsychotics
Functional hypothalamic amenorrheaLow energy availability, weight loss, intense exercise, stress — part of the female athlete triad (low energy availability, menstrual dysfunction, low bone density)
2.Assessment Findings

Menstrual history

  • Age at menarche, cycle length, duration, last menstrual period (LMP), regularity
  • Quantify bleeding: number of pads or tampons soaked, need to change every 1–2 hours, clots larger than about 2.5 cm (1 inch), flooding at night, days missed from school or work
  • Pain: timing with menses, severity, response to analgesics, dyspareunia, bowel symptoms

Anemia and hemodynamic status (priority with heavy bleeding)

  • Fatigue, dizziness, pallor, dyspnea on exertion, tachycardia, orthostatic hypotension, pica

Other findings

  • PCOS: irregular cycles, hirsutism, acne, central obesity, acanthosis nigricans
  • Hyperprolactinemia: galactorrhea, headache, visual field loss (pituitary tumor)
  • Hypothalamic amenorrhea: low body mass index, restrictive eating, stress fractures
  • PMS/PMDD: breast tenderness, bloating, weight gain, irritability, depressed mood — screen for suicidal thoughts in PMDD
3.Diagnostics
  • Pregnancy test (urine or serum hCG) first for any reproductive-age client with amenorrhea or abnormal bleeding
  • CBC and ferritin with heavy bleeding; coagulation studies and von Willebrand evaluation when heavy bleeding began at menarche or there is a bleeding history
  • TSH, prolactin; FSH/LH and estradiol (ovarian insufficiency); total testosterone for hyperandrogenism
  • Transvaginal pelvic ultrasound — first-line imaging for structural causes (polyps, fibroids, adenomyosis) and ovarian morphology
  • Endometrial biopsy — for AUB in clients 45 years and older, or younger with prolonged unopposed estrogen exposure (obesity, PCOS) or failed treatment
  • Symptom diary for at least 2 cycles to confirm the luteal timing of PMS/PMDD
  • PCOS diagnosis (Rotterdam criteria, used by the 2023 international guideline): 2 of 3 — ovulatory dysfunction, clinical or biochemical hyperandrogenism, polycystic ovarian morphology on ultrasound (or high anti-Müllerian hormone in adults), after excluding other causes
  • Female athlete: bone density (DXA) after about 6 months of amenorrhea or with stress fractures
4.Medical Management
Drug / classUseKey safety points
NSAIDs (ibuprofen, naproxen, mefenamic acid)First-line for primary dysmenorrhea; also reduce heavy bleedingStart at onset of menses or pain (or 1–2 days before) and take on schedule for 2–3 days; take with food. GI bleeding, kidney injury, raised blood pressure; avoid with peptic ulcer, kidney disease, aspirin/NSAID-sensitive asthma, anticoagulants, and pregnancy from 20 weeks (avoid in the third trimester)
Combined hormonal contraceptivesDysmenorrhea, heavy bleeding, PCOS, PMS/PMDD (drospirenone–ethinyl estradiol)Contraindicated with smoking at age 35 or older, history of VTE or stroke, migraine with aura, uncontrolled hypertension, breast cancer, liver disease. Teach ACHES warning signs (Abdominal pain, Chest pain, Headaches, Eye problems, Severe leg pain). Drospirenone can raise potassium — caution with kidney or adrenal disease and with potassium-sparing diuretics, ACE inhibitors, or ARBs
Levonorgestrel IUDMost effective medical treatment for heavy menstrual bleedingIrregular spotting early; rare perforation or expulsion
Tranexamic acidHeavy bleeding — taken only during menses (up to 5 days)Antifibrinolytic — contraindicated with active or past thromboembolism; caution with combined hormonal contraceptives
Progestins (oral or injectable)Ovulatory dysfunction; endometrial protectionIrregular bleeding, mood change, weight gain; injectable medroxyprogesterone causes reversible bone loss
SSRIs (fluoxetine, sertraline, paroxetine)First-line drug for PMDD; continuous or luteal-phase dosingNausea, sexual dysfunction, insomnia; suicidality warning in young people; serotonin syndrome risk with other serotonergic drugs
MetforminPCOS with insulin resistanceGI upset, lactic acidosis risk with kidney impairment
LetrozoleFirst-line ovulation induction in PCOS (off-label)Rule out pregnancy before each cycle and stop if pregnant; hot flashes, dizziness, fatigue; monitor for multiple pregnancy
Dopamine agonists (cabergoline, bromocriptine)Hyperprolactinemia / prolactinoma — first-line even for most macroadenomasNausea, orthostatic hypotension (take at bedtime with food), impulse-control changes; cabergoline at high doses — cardiac valve disease
Iron (oral)Iron-deficiency anemiaBest absorbed on an empty stomach with vitamin C; take with food if GI upset; separate from dairy, calcium, antacids, tea/coffee; dark stools, constipation

Procedures — hysteroscopic removal of polyps or submucosal fibroids; endometrial ablation for heavy bleeding when childbearing is complete; hysterectomy as definitive therapy.

Acute heavy bleeding with instability — IV access, fluids, type and crossmatch, transfusion as needed; high-dose IV or oral hormones or tranexamic acid per provider; rarely uterine tamponade or curettage.

5.Nursing Interventions

Listed in priority order.

  1. Assess hemodynamic status with heavy bleeding — vital signs (pulse, blood pressure, orthostatic changes), level of consciousness, pad count or weight (1 g ≈ 1 mL), hemoglobin; report tachycardia, hypotension, or soaking a pad every hour for 2 or more hours
  2. Safety with anemia — rise slowly (sit before standing), assist with ambulation, fall precautions
  3. Rule out pregnancy before tests or drugs in amenorrhea or AUB
  4. Pain management — scheduled NSAIDs as ordered, heat to the lower abdomen or back, exercise, rest; reassess pain response
  5. Administer and monitor drugs — check contraindications before hormonal therapy (smoking, VTE, migraine with aura, blood pressure); give iron correctly
  6. Emotional support and screening — PMDD: screen for depression and suicidal ideation; PCOS: body image, weight stigma, fertility worries
  7. Refer — gynecology, endocrinology, dietitian, sports medicine, or mental health as indicated
6.Client Education
  • Menstrual hygiene
    • Change pads when soaked; change tampons every 4–8 hours and never leave one in longer than 8 hours; use the lowest absorbency needed; alternate with pads at night if preferred; wash hands before and after insertion
    • Toxic shock syndrome (TSS) warning signs: sudden high fever, vomiting, diarrhea, sunburn-like rash, dizziness, or low blood pressure — remove the tampon and seek care immediately
    • Menstrual cups: empty and clean per manufacturer; the same TSS precautions apply
    • Do not douche; avoid scented pads and feminine sprays
  • Dysmenorrhea: start NSAIDs at the first sign of pain or bleeding; regular aerobic exercise and heat help; report pain that worsens over time, pain not relieved by NSAIDs, or pain with intercourse — these suggest secondary causes
  • PMS: keep a symptom diary; limit salt (reduces bloating), caffeine, alcohol, and refined sugar; small frequent meals with complex carbohydrates; regular aerobic exercise; adequate sleep and stress reduction; calcium-rich diet
  • PCOS: modest weight loss (5–10%) can restore ovulation; balanced diet and regular exercise to improve insulin resistance — no single diet is required; long-term risks include diabetes, dyslipidemia, sleep apnea, and endometrial hyperplasia, so regular screening matters
  • Fertility awareness: ovulation occurs about 14 days before the next period, not always on day 14
  • Athletes: missed periods are not a normal effect of training; adequate energy intake, calcium, and vitamin D protect bone
  • Iron: continue for about 3 months after hemoglobin normalizes to refill stores; keep out of reach of children (overdose is dangerous)
7.Complications & Red Flags
ComplicationWarning signsPriority action
Hemorrhage / hypovolemiaTachycardia, hypotension, dizziness, syncope, soaking pads hourlyLie flat, IV access, notify provider, CBC and type and crossmatch
Iron-deficiency anemiaFatigue, pallor, dyspnea, low hemoglobin and ferritinIron replacement; treat cause
Ectopic pregnancy mimicking menstrual painMissed period, unilateral pelvic pain, spotting, shoulder pain, shockhCG and ultrasound; emergency if unstable
Ovarian cyst rupture or torsionSudden unilateral pain (torsion: severe pain with nausea and vomiting)Urgent evaluation — torsion is a surgical emergency
Toxic shock syndromeFever, rash, hypotension, multiorgan signsRemove tampon, sepsis care
Bone loss / stress fracturesProlonged hypothalamic amenorrhea, low weightRestore energy balance, DXA, calcium and vitamin D
Endometrial hyperplasia or cancerChronic anovulation (PCOS, obesity) with prolonged unopposed estrogenEndometrial sampling; progestin protection
Suicidality in PMDDHopelessness, self-harm talkSafety assessment, urgent mental health referral
8.High-Yield Points
  • Follicular phase: FSH matures follicles, estrogen builds a proliferative lining; LH surge triggers ovulation
  • Luteal phase: corpus luteum progesterone creates a secretory endometrium; it lasts about 14 days
  • Ovulation ≈ 14 days before the next menses
  • Amenorrhea → pregnancy test first
  • Heavy bleeding: assess vital signs and anemia first; quantify pads
  • Primary dysmenorrhea = prostaglandins, no pathology → NSAIDs first-line
  • PMS: limit salt, caffeine, alcohol; exercise; PMDD first-line drug = SSRI
  • PCOS: irregular cycles + hirsutism/acne + insulin resistance → weight management, metformin, hormonal contraceptives
  • Prolactinoma → dopamine agonist (cabergoline, bromocriptine)
  • Tampons: lowest absorbency, change every 4–8 h, never over 8 h (TSS)
  • Athlete amenorrhea → low bone density and stress fractures
  • Iron: do not take with dairy, calcium, or antacids

Country Notes

United States

  • Adolescent guidance treats the menstrual cycle as a vital sign: cycles persistently shorter than 21 days or longer than 45 days, or bleeding more than 7 days, warrant evaluation.
  • FDA tampon labeling uses standardized absorbency terms and carries TSS warnings on the package insert.

Philippines

  • Thalassemia and other hemoglobin variants occur in the population; microcytic anemia in a menstruating woman may not be iron deficiency alone — check ferritin before long-term iron.
  • The Responsible Parenthood and Reproductive Health Act of 2012 (RA 10354) provides for access to modern family planning methods in public facilities, which include hormonal methods used for menstrual disorders.

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.